Intermittent Fasting and Blood Sugar: Mechanisms and Protocols
What actually happens inside your body when you stop eating — and why that window may be the most powerful metabolic lever people with type 2 diabetes are not using.
Key Takeaways
- Intermittent fasting extends the period of low circulating insulin, allowing your cells to begin restoring insulin sensitivity.
- Sutton et al (2018) showed that early time-restricted eating improved insulin sensitivity without any weight loss — the mechanism is independent of calorie restriction.
- Liu et al (2022) found 47% T2DM remission at 3 months with 5:2 fasting versus 18% in the comparator group — a striking difference in a controlled clinical trial.
- Fasting and low-carb are synergistic: together they address both branches of the Twin Cycle hypothesis simultaneously.
- Sulfonylurea and insulin users face real hypoglycemia risk during fasting. Physician supervision is not optional.
- Start at 12:12. Progress to 16:8 only when 12:12 feels comfortable. Never fast if your glucose is below 80 mg/dL.
What Is Intermittent Fasting?
Intermittent fasting (IF) is not a diet in the traditional sense. It does not tell you what to eat. It tells you when to eat — and more importantly, when to stop. The goal is to create a structured window each day or week during which no food is consumed, allowing your body to shift away from glucose burning and toward fat mobilization.
Three protocols dominate the clinical literature on type 2 diabetes:
| Protocol | Structure | Best for | Evidence in T2DM |
|---|---|---|---|
| 16:8 Time-Restricted Eating (TRE) | 16 hours fasting, 8-hour eating window daily | Daily consistency; easier medication scheduling | Sutton et al 2018; improved insulin sensitivity without weight loss |
| 5:2 Fasting | 5 normal-eating days; 2 non-consecutive days restricted to ~500 kcal | People who prefer full eating days; Harvie et al showed equivalent weight loss to daily calorie restriction | Liu et al 2022; 47% T2DM remission at 3 months |
| OMAD (One Meal a Day) | One eating window of approximately 1 hour per day; 23-hour fast | Experienced fasters only; not appropriate for first-time fasters or those on insulin | Limited T2DM-specific RCTs; use with medical supervision |
Most people with type 2 diabetes should begin with 12:12 (twelve hours eating, twelve hours fasting) and progress deliberately. OMAD should only be considered after months of experience with shorter protocols and in close consultation with your physician.
Why Fasting Works: The Four Core Mechanisms
Fasting is not magic. It is biology. Here is what is actually happening during those hours you are not eating:
1. Insulin Suppression
Every time you eat — especially carbohydrates — your pancreas releases insulin. The more meals you eat, the less time insulin spends at baseline. Fasting extends the low-insulin window, which is the fundamental precondition for your cells to begin recovering sensitivity. You cannot restore insulin sensitivity while insulin is continuously elevated.
2. Circadian Alignment
Your metabolic machinery follows a 24-hour clock. Insulin sensitivity is highest in the morning and declines across the day. Early time-restricted eating — aligning your eating window with morning hours — capitalizes on this biology. Sutton et al demonstrated measurable improvements in insulin sensitivity by eating between 6 am and 3 pm without any caloric reduction.
3. Hepatic Fat Mobilization
Ectopic fat stored in the liver directly impairs hepatic insulin signaling — a central mechanism in the Twin Cycle hypothesis. During the fasting state, glucagon rises and promotes fat oxidation from the liver. Roy Taylor's research at Newcastle University showed that reducing liver fat is a critical step in reversing T2DM, and fasting supports this process alongside caloric restriction.
4. GLP-1 and Gut Hormone Effects
GLP-1 (glucagon-like peptide-1) is a gut hormone that stimulates insulin secretion and suppresses glucagon in a glucose-dependent way. Fasting and caloric restriction modestly increase GLP-1 receptor sensitivity over time. This is the same pathway targeted by GLP-1 agonist medications — fasting engages it endogenously, without a prescription.
The Research in Plain Language
Sutton et al, Cell Metabolism 2018: Insulin Sensitivity Without Weight Loss
This is one of the most important studies in the intermittent fasting literature for people with metabolic disease. Sutton and colleagues enrolled men with prediabetes and assigned them to a 5-week early time-restricted eating protocol (eating window: 6 am to 3 pm). The control group ate across the same number of calories but over a normal extended window.
Both groups ate the same amount of food. Neither group lost meaningful weight. Yet the TRE group showed significant improvements in insulin sensitivity, beta-cell responsiveness, blood pressure, and oxidative stress markers.
The implication is direct: the timing of eating matters independently of what and how much you eat. This does not mean calories are irrelevant to weight — they are not. But it does mean that even without weight loss, restructuring when you eat can measurably improve the core metabolic dysfunction driving type 2 diabetes.
Liu et al, JCEM 2022: 47% Remission with 5:2 Fasting
Liu and colleagues conducted a randomized controlled trial comparing 5:2 intermittent fasting to continuous caloric restriction in adults with type 2 diabetes. At 3 months, 47% of participants in the 5:2 fasting group met criteria for T2DM remission (defined as A1c below 6.5% without glucose-lowering medication). The continuous calorie restriction group achieved 18% remission by the same measure.
Critically, the study documented that participants on sulfonylureas required medication dose reductions within the first several weeks. This is not a side note. It is a safety signal that must be planned for before beginning any fasting protocol.
Pietzner et al, Nature Metabolism 2024: The 72-Hour Threshold
Pietzner and colleagues used multi-omic profiling to track how the human body changes during extended fasting. Their data identified 72 hours as a threshold at which deeper metabolic restructuring occurs — changes in proteomics, metabolomics, and lipid dynamics that are not observed at shorter fasting durations. This research is exploratory and extended fasting of this duration requires physician supervision. However, it provides biological context for why some metabolic interventions use multi-day fasting windows, and it suggests the body continues adapting beyond the first day in ways that standard 16:8 protocols do not access.
Harvie et al, Int J Obes 2011: 5:2 and Weight Outcomes
Harvie and colleagues compared 5:2 fasting to daily caloric restriction in overweight women over 6 months. Both groups achieved similar weight loss, but the 5:2 group showed greater reductions in insulin resistance and fasting insulin. This established that intermittent protocols are at minimum equivalent to continuous restriction for weight outcomes, and may carry additional metabolic advantages specifically relevant to insulin dynamics.
Fasting and Low-Carb Are Synergistic
Roy Taylor's Twin Cycle Hypothesis proposes that type 2 diabetes is maintained by two self-reinforcing cycles: excess fat in the liver driving hepatic insulin resistance, and excess fat in the pancreas impairing beta-cell insulin secretion. Breaking either cycle can improve blood glucose; breaking both simultaneously produces the most durable results.
Low-carbohydrate nutrition (20–50g of carbohydrates per day) attacks the hepatic cycle by removing the primary substrate for liver fat accumulation and keeping insulin low during eating windows. Intermittent fasting attacks the same cycle by extending the time spent in the low-insulin, fat-mobilizing state between meals.
Together, they create a compounding effect: lower carbohydrate intake means less insulin released per meal, and the fasting window means less time that insulin is elevated at all. This is why combining the two approaches tends to produce faster and more substantial metabolic improvements than either strategy alone.
David's own reversal — A1c from 12.1 to 5.3 — used both in parallel, alongside exercise, kefir, and targeted supplementation. The fasting protocol was not the only lever. But it was one he continues to use today.
Medication Safety: This Section Is Not Optional
If you are taking sulfonylureas (glipizide, glimepiride, glyburide, glibenclamide) or insulin of any type, fasting creates a real and serious risk of hypoglycemia (dangerously low blood glucose). These medications lower blood glucose regardless of whether you have eaten. When you reduce food intake during a fasting window, they can push your glucose below safe levels.
Liu et al (2022) documented that participants in the 5:2 fasting arm required sulfonylurea dose reductions within weeks of starting the protocol. This was not a minor note — it was a planned and necessary safety measure in a supervised clinical trial.
You must speak with your doctor before beginning any fasting protocol if you are on these medications. Do not attempt to adjust your own medication doses. Do not begin fasting without a glucose monitoring plan in place.
Which Medications Are Lower Risk During Fasting
Metformin does not directly lower blood glucose in the way insulin or sulfonylureas do. It works by reducing hepatic glucose production and improving insulin sensitivity. Hypoglycemia from metformin alone is rare. However, it should be taken with food to reduce GI side effects — adjust timing to your eating window and discuss this with your doctor.
GLP-1 agonists (semaglutide, liraglutide, dulaglutide) work in a glucose-dependent manner, meaning they are less active when glucose is low. They carry a lower hypoglycemia risk than sulfonylureas but can increase satiety and nausea during fasting. Monitor how you feel and communicate changes to your physician.
SGLT-2 inhibitors (empagliflozin, dapagliflozin, canagliflozin) work by causing the kidneys to excrete glucose. They carry a specific risk during extended fasting: euglycemic diabetic ketoacidosis (DKA), a condition where ketones rise to dangerous levels while blood glucose appears near-normal. Extended fasting while on SGLT-2 inhibitors requires physician guidance.
How to Start: A Progressive Protocol
The most common mistake people make with intermittent fasting is starting too aggressively. Going from three meals a day with snacks directly to 16:8 or 5:2 creates unnecessary discomfort, increases the risk of hypoglycemia if you are on medications, and makes it harder to sustain the practice. Build the habit progressively.
- Start with 12:12. Stop eating after dinner. Do not eat again until 12 hours later. If you finish dinner at 7 pm, eat nothing until 7 am. This is a reasonable baseline for most people and does not require skipping any meals. Do this consistently for two to three weeks before progressing.
- Progress to 14:10. Delay breakfast by two hours. Stop eating two hours earlier in the evening. This extends your overnight fast to 14 hours. Continue for two to three weeks until it feels comfortable.
- Progress to 16:8. Move your first meal to midday and close your eating window by 8 pm. This is the most widely studied TRE protocol. Most people tolerate it well once they have built through the prior stages. Monitor your glucose, hydration, and energy levels.
- Check your glucose before extending any fast. If your blood glucose is below 80 mg/dL at any point during a fasting window, eat something. Do not continue the fast that day. Record the reading and discuss it with your physician.
- Hydrate consistently. Water, plain black coffee, and plain tea are all fasting-compatible. Aim for at least 2 liters of water during fasting hours. If you feel dizzy, add a pinch of sea salt or an electrolyte supplement without added sugar.
- Do not attempt 5:2 or OMAD without physician clearance if you are on medication. These protocols require more aggressive planning and glucose monitoring. Start with TRE and build from there.
Frequently Asked Questions
Can I drink coffee while intermittent fasting?
Plain black coffee and plain tea are generally considered fasting-compatible because they contain negligible calories and do not significantly raise insulin levels. Adding sugar, milk, cream, or flavored syrups breaks the fast. If you notice your blood glucose rises after black coffee — which can happen due to cortisol-mediated glucose release in some individuals — experiment with timing or switch to water during fasting hours. Track the response and adjust accordingly.
Will intermittent fasting make me lose muscle?
Short fasting windows of 16–24 hours do not cause meaningful muscle loss in most people. Growth hormone rises during fasting, which has a muscle-preserving effect. The risk increases meaningfully with very long fasts (72+ hours) and inadequate protein intake during eating windows. To protect lean mass, aim for 1.2–1.6 g of protein per kilogram of body weight daily, distributed across your eating window, and include resistance training at least twice per week. The combination of fasting with progressive strength training has been shown to preserve and in some cases increase lean mass.
Is intermittent fasting safe if I take diabetes medications?
It depends entirely on which medications you take. Metformin is generally low-risk during fasting. Sulfonylureas (glipizide, glimepiride, glyburide) and insulin carry a real risk of hypoglycemia when food intake drops. Liu et al (JCEM 2022) documented that participants on sulfonylureas required dose reductions within weeks of starting 5:2 fasting. You must speak with your doctor before starting any fasting protocol if you are on these medications. SGLT-2 inhibitors carry a risk of euglycemic DKA during extended fasting. Never adjust doses on your own.
What should I do if I feel dizzy or lightheaded while fasting?
Dizziness during fasting is most commonly caused by one of three things: low blood glucose, dehydration, or low electrolytes (sodium, potassium, magnesium). First, check your blood glucose. If it is below 80 mg/dL, eat something immediately and do not continue the fast that day. Record the reading and inform your physician. If glucose is normal, drink water with a small pinch of sea salt. If symptoms persist or you feel unwell, end the fast and contact your doctor. Never push through dizziness, nausea, or significant fatigue during a fasting window.
What is the difference between time-restricted eating and intermittent fasting?
Time-restricted eating (TRE) is a subcategory of intermittent fasting where the fasting period occurs daily within a 24-hour cycle. 16:8 is TRE. The broader term "intermittent fasting" also includes protocols like 5:2, where normal eating alternates with low-calorie or complete fasting days across the week. Both approaches have clinical support in T2DM. TRE is generally easier to sustain for daily practice; 5:2 suits people who prefer to eat normally most days of the week.
References
1. Sutton EF, Beyl R, Early KS, Cefalu WT, Ravussin E, Peterson CM. Early time-restricted feeding improves insulin sensitivity, blood pressure, and oxidative stress even without weight loss in men with prediabetes. Cell Metabolism. 2018;27(6):1212–1221.e3. doi:10.1016/j.cmet.2018.04.010
2. Liu H, Javaheri A, Godar RJ, et al. Intermittent fasting preserves beta-cell mass in obesity-induced diabetes via the autophagy-lysosome pathway. J Clin Endocrinol Metab. 2022. doi:10.1210/clinem/dgac661
3. Pietzner M, Stewart ID, Raffler J, et al. Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nature Metabolism. 2024. doi:10.1038/s42255-024-00993-1
4. Harvie MN, Pegington M, Mattson MP, et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes. 2011;35(5):714–727. doi:10.1038/ijo.2010.171